Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.
| Website | https://lightcast.bio |
| Revenue | $12.7 million |
| Employees | 98 (73 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Assay Development, Platform Technology, Single Cell Analysis, High Throughput Screening, Cell Biology, Biotechnology Platform, Drug Discovery Platform, Biotechnology, Life Science Research, Biomedical Research, Microfluidics, Lab On A Chip, Diagnostic Tools, Precision Medicine, Biotechnology Tools, Research Tools |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, 10x Genomics, Oxford Nanopore Technologies, PacBio, Bionano Genomics, Inc., GenomeWeb +34 more (view full list) |
Looking for a particular Lightcast employee's phone or email?
The Lightcast annual revenue was $12.7 million in 2026.
Paul Loeffen is the CEO of Lightcast.
73 people are employed at Lightcast.